Table 3.
Mutations in V3-23-Cγ transcript sequences from PBMC from controls and CVID patients
| Clones
|
Mutations
|
R/S
|
||||
|---|---|---|---|---|---|---|
| All | Unmutated | Total | per bp, % | CDRs | FRs | |
| Controls | ||||||
| ND3 | 18 | 0 | 410* | 7.9 | 2.05 | 1.07 |
| ND4 | 11 | 0 | 226* | 7.1 | 4.68 | 1.2 |
| Patients | ||||||
| LE | 21 | 15 | 50 | 0.8 | 1.75 | 1.5 |
| SO | 19 | 8 | 90 | 1.6 | 3.25 | 1.29 |
| FL | 8 | 0 | 118* | 5.1 | 1.55 | 1.02 |
| BE | 8 | 0 | 125 | 5.4 | 3.54 | 1.08 |
| MA | 7 | 1 | 108* | 5.4 | 3.6 | 1.36 |
| TH | 4 | 0 | 71* | 6.2 | 4.16 | 2.54 |
Including one deletion or insertion.